(R21) Limited Competition: Exploratory CTSA Collaborative Innovation Awards

August 7, 2017 National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, collaborative research projects in the NCATS’ Clinical and Translational Science Award (CTSA) program, with the goal of assessing utility and feasibility of proposed innovation(s).

Application Due Dates

  • November 29, 2017
  • March 29, 2018
  • July 30, 2018

Eligibility Requirements

This is a limited competition FOA. Applications must involve investigators from at least 2 active CTSA institutions.  For the purpose of this FOA, a CTSA institution is defined as the prime recipient of an active CTSA (U54/UL1) award or an active partner institution identified in the competing application for the CTSA award.  To apply for this FOA, the CTSA institutions identified must be affiliated with CTSA awards (U54/UL1) that are active as of the application due date.

Applications must involve investigators from at least 2 CTSA Institutions.  The PD/PI, or contact PD/PI in applications using the multiple PD/PI option, must be employed by an Institution that is a prime recipient of an active CTSA (U54/UL1) award or an active partner institution identified in the competing application for the CTSA award.  The CTSA institutions identified must be affiliated with CTSA awards (U54/UL1) that are active as of the application due date.

Investigators who are not employed by an institution serving as a prime recipient or a partner institution for an active CTSA award (U54/UL1) may co-direct a project using the Multiple PD/PI option; however, these individuals may not serve as the contact PD/PI. 

Amount

$275,000

Read the full funding announcement